A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...
MedPage Today on MSNOpinion
Recent developments in prostate cancer
Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...
Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...
Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer ...
1don MSN
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...
Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...
Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
Prostate enlargement is a common age-related condition affecting millions of men. Learn about its symptoms, risk factors, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results